GETINGE Gross Margin 2016-2024 | GNGBY
Current and historical gross margin for GETINGE (GNGBY) over the last 10 years. The current gross profit margin for GETINGE as of September 30, 2024 is %.
| GETINGE Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $3.21B | $1.47B | 45.79% |
| 2024-06-30 | $3.16B | $1.46B | 46.26% |
| 2024-03-31 | $3.04B | $1.38B | 45.35% |
| 2023-12-31 | $3.00B | $1.37B | 45.50% |
| 2023-09-30 | $2.87B | $1.32B | 46.03% |
| 2023-06-30 | $2.83B | $1.31B | 46.38% |
| 2023-03-31 | $2.83B | $1.34B | 47.36% |
| 2022-12-31 | $2.80B | $1.33B | 47.40% |
| 2022-09-30 | $2.91B | $1.41B | 48.67% |
| 2022-06-30 | $2.98B | $1.46B | 48.89% |
| 2022-03-31 | $3.08B | $1.54B | 50.05% |
| 2021-12-31 | $3.15B | $1.58B | 50.16% |
| 2021-09-30 | $3.25B | $1.61B | 49.46% |
| 2021-06-30 | $3.42B | $1.71B | 50.04% |
| 2021-03-31 | $3.36B | $1.66B | 49.51% |
| 2020-12-31 | $3.25B | $1.61B | 49.37% |
| 2020-09-30 | $3.13B | $1.56B | 49.65% |
| 2020-06-30 | $2.89B | $1.40B | 48.39% |
| 2020-03-31 | $2.83B | $1.34B | 47.44% |
| 2019-12-31 | $2.81B | $1.32B | 46.89% |
| 2019-09-30 | $2.81B | $1.29B | 46.02% |
| 2019-06-30 | $2.79B | $1.26B | 45.03% |
| 2019-03-31 | $2.79B | $1.26B | 45.19% |
| 2018-12-31 | $2.78B | $1.27B | 45.76% |
| 2018-09-30 | $2.14B | $0.97B | 45.03% |
| 2018-06-30 | $2.33B | $1.09B | 46.61% |
| 2018-03-31 | $2.49B | $1.17B | 47.01% |
| 2017-12-31 | $2.64B | $1.24B | 47.14% |
| 2017-09-30 | $3.46B | $1.65B | 47.54% |
| 2017-06-30 | $3.45B | $1.64B | 47.43% |
| 2017-03-31 | $3.47B | $1.63B | 46.97% |
| 2016-12-31 | $3.48B | $1.62B | 46.52% |
| 2016-09-30 | $3.52B | $2.23B | 63.48% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.000B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.844B | 10.53 |
| Cencora (COR) | United States | $43.438B | 16.33 |
| DiDi Global (DIDIY) | China | $22.990B | 0.00 |
| Natera (NTRA) | United States | $21.203B | 0.00 |
| ICON (ICLR) | Ireland | $17.541B | 15.62 |
| Viatris (VTRS) | United States | $14.824B | 4.57 |
| Avantor (AVTR) | United States | $14.429B | 21.63 |
| Revvity (RVTY) | United States | $13.631B | 23.68 |
| BioMerieux (BMXMF) | France | $12.250B | 0.00 |
| CochLear (CHEOY) | Australia | $11.924B | 0.00 |
| Solventum (SOLV) | United States | $11.390B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.405B | 29.31 |
| Doximity (DOCS) | United States | $9.999B | 58.86 |
| Charles River Laboratories (CRL) | United States | $9.340B | 18.05 |
| HealthEquity (HQY) | United States | $8.390B | 42.09 |
| Sonic Healthcare (SKHHY) | Australia | $8.095B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.339B | 29.51 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.858B | 20.64 |
| Organon (OGN) | United States | $3.853B | 3.89 |
| BrightSpring Health Services (BTSG) | United States | $3.018B | 64.18 |
| Surgery Partners (SGRY) | United States | $2.706B | 30.85 |
| Concentras Parent (CON) | United States | $2.456B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.405B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.216B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.188B | 0.00 |
| Premier (PINC) | United States | $2.054B | 10.69 |
| PACS (PACS) | United States | $1.971B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.738B | 45.60 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.720B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.639B | 0.00 |
| Progyny (PGNY) | United States | $1.510B | 30.57 |
| Establishment Labs Holdings (ESTA) | $1.268B | 0.00 | |
| Embecta (EMBC) | United States | $1.177B | 8.23 |
| CareDx (CDNA) | United States | $1.154B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.119B | 10.95 |
| AMN Healthcare Services Inc (AMN) | United States | $0.935B | 6.33 |
| Agilon Health (AGL) | United States | $0.791B | 0.00 |
| SBC Medicals (SBC) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.566B | 14.81 |
| InnovAge Holding (INNV) | United States | $0.534B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| DocGo (DCGO) | United States | $0.438B | 16.50 |
| Sonida Senior Living (SNDA) | United States | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.390B | 33.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.284B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.281B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.237B | 0.00 |
| LifeMD (LFMD) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.215B | 0.00 |
| MultiPlan (MPLN) | United States | $0.209B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| Nutex Health (NUTX) | United States | $0.189B | 0.00 |
| ModivCare (MODV) | United States | $0.177B | 9.60 |
| So-Young (SY) | China | $0.097B | 16.41 |
| Ascend Wellness Holdings (AAWH) | United States | $0.093B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.022B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |